| 1 | YANG Y, MENG L, WU S, et al.. LIGHT deficiency aggravates cisplatin-induced acute kidney injury by upregulating mitochondrial apoptosis[J/OL]. Int. Immunopharmacol., 2020, 89: 106999[2022-11-20]. . | 
																													
																							| 2 | HU J, GU W, MA N, et al.. Leonurine alleviates ferroptosis in cisplatin‐induced acute kidney injury by activating the Nrf2 signalling pathway[J]. Br. J. Pharmacol., 2022, 179(15): 3991-4009. | 
																													
																							| 3 | FANG C, LOU D, ZHOU L, et al.. Natural products: potential treatments for cisplatin-induced nephrotoxicity[J]. Acta. pharmacol. Sin., 2021, 42(12): 1951-1969. | 
																													
																							| 4 | 孟利,杨雁,张克勤,等.Fgl2在顺铂诱导的小鼠急性肾损伤中的作用及机制研究[J].免疫学杂志,2021,37(2):93-99. | 
																													
																							| 5 | 张术姣,谭小月,张勉之.丹参提取物对顺铂诱导小鼠急性肾损伤的影响及机制研究[J].中华中医药杂志,2021,36(12):7324-7328. | 
																													
																							| 6 | WANG B, HUANG C, LIU L, et al.. Pim1 kinase inhibitors exert anti-cancer activity against HER2-positive breast cancer cells through downregulation of HER2[J/OL]. Front. Pharmacol., 2021, 12: 614673[2022-11-22]. . | 
																													
																							| 7 | EBEID D E, FIROUZI F, ESQUER C Y, et al.. PIM1 promotes survival of cardiomyocytes by upregulating c-Kit protein expression[J/OL]. Cells, 2020, 9(9): 2001[2022-11-21]. . | 
																													
																							| 8 | ZHU H, WANG X, SUN Y, et al.. Pim1 overexpression prevents apoptosis in cardiomyocytes after exposure to hypoxia and oxidative stress via upregulating cell autophagy[J]. Cell Physiol. Biochem., 2018, 49(6): 2138-2150. | 
																													
																							| 9 | ANDREUCCI M, FAGA T, PISANI A, et al.. Quercetin protects against radiocontrast medium toxicity in human renal proximal tubular cells[J]. J. Cell Physiol., 2018, 233(5): 4116-4125. | 
																													
																							| 10 | SEIFERT C, BALZ E, HERZOG S, et al.. PIM1 inhibition affects glioblastoma stem cell behavior and kills glioblastoma stem-like cells[J/OL]. Int. J. Mol. Sci., 2021, 22(20): 11126[2022-11-22]. . | 
																													
																							| 11 | WU J, CHU E, KANG Y. PIM kinases in multiple myeloma[J/OL]. Cancers, 2021, 13(17): 4304[2022-11-22]. . | 
																													
																							| 12 | YUAN Y, WANG C, ZHUANG X, et al.. PIM1 promotes hepatic conversion by suppressing reprogramming-induced ferroptosis and cell cycle arrest[J]. Nat. Commun., 2022, 13(1): 5237-5356. | 
																													
																							| 13 | CHAUHAN S S, TOTH R K, JENSEN C C, et al.. PIM kinases alter mitochondrial dynamics and chemosensitivity in lung cancer[J]. Oncogene, 2020, 39(12): 2597-2611. | 
																													
																							| 14 | ZHAO B, LIU L, MAO J, et al.. PIM1 mediates epithelial-mesenchymal transition by targeting Smads and c-Myc in the nucleus and potentiates clear-cell renal-cell carcinoma oncogenesis[J/OL]. Cell Death. Dis., 2018, 9(3): 307[2022-11-22]. . | 
																													
																							| 15 | 李侃,肖啸,周森,等.自噬途径在急性肾损伤中的作用及靶向治疗策略研究进展[J].中国综合临床,2022,38(5):466-470. | 
																													
																							| 16 | 熊哲学,李凝旭,唐明娟.钠-葡萄糖协同转运蛋白2抑制剂对足细胞自噬影响及其肾脏保护机制的研究进展[J].中国糖尿病杂志,2022,30(7):554-557. | 
																													
																							| 17 | 金丽霞,张晓东,潘超,等.中医药调控线粒体自噬防治慢性肾脏病的研究进展[J].中国中药杂志,2022,47(13):3432-3438. | 
																													
																							| 18 | KLIONSKY D J, PETRONI G, AMARAVADI R K, et al.. Autophagy in major human diseases[J/OL]. EMBO J., 2021, 40(19): e108863[2022-12-07]. . | 
																													
																							| 19 | KONG L, DENG J, ZHOU X, et al.. Sitagliptin activates the p62-Keap1-Nrf2 signalling pathway to alleviate oxidative stress and excessive autophagy in severe acute pancreatitis-related acute lung injury[J/OL]. Cell Death. Dis., 2021, 12(10): 928[2022-12-07]. . | 
																													
																							| 20 | JIANG K, XU Y, WANG D, et al.. Cardioprotective mechanism of SGLT2 inhibitor against myocardial infarction is through reduction of autosis[J]. Protein Cell, 2022, 13(5): 336-359. | 
																													
																							| 21 | 王珍,杨洛,廖敏,等.mTOR信号通路在糖尿病肾病发病机制中的研究进展[J].生物技术进展,2021,11(3):316-321. | 
																													
																							| 22 | XU J, SHAN X, CHEN C, et al.. Tangshenning attenuates high glucose-induced podocyte injury via restoring autophagy activity through inhibiting mTORC1 activation[J/OL]. J. Diabetes. Res., 2022, 2022: 1610416[2022-12-08]. . | 
																													
																							| 23 | TAN X, ZHU H, TAO Q, et al.. FGF10 protects against renal ischemia/reperfusion injury by regulating autophagy and inflammatory signaling[J/OL]. Front. Genet., 2018, 9: 556[2022-11-22]. . | 
																													
																							| 24 | ZHOU J, FAN Y, ZHONG J, et al.. TAK1 mediates excessive autophagy via p38 and ERK in cisplatin‐induced acute kidney injury[J]. J. Cell Mol. Med., 2018, 22(5): 2908-2921. | 
																													
																							| 25 | ZHOU L, ZHANG L, ZHANG Y, et al.. PINK1 deficiency ameliorates cisplatin-induced acute kidney injury in rats[J/OL]. Front. Physiol., 2019, 10: 1225[2022-11-23]. . |